Coronary Stent Market Size & Share, By Product Type (Drug Eluting Stents, Bioabsorbable Stents), Design (Permanent coronary Stents, Fully degradable coronary stents), Material (Metallic, Polymeric), End-User (Hospitals, Cardiac Centers), Regional Forecast, Industry Players, Growth Statistics Report 2024-2035

Market Outlook:

Coronary Stent Market size exceeded USD 7.84 Billion in 2023 and is estimated to cross USD 21.63 Billion by 2035, growing at over 11.32% CAGR during 2024 to 2035.

• Base Year Value (2023): USD 7.84 Billion
• CAGR (2024-2035): 11.32%
• Forecast Year Value (2035): USD 21.63 Billion
• Historical Data Period: 2019-2022
• Largest Region: North America
• Forecast Period: 2024-2035

Market Dynamics:

The global coronary stent market is expected to experience significant growth in the coming years, driven by several key factors. The increasing prevalence of coronary artery disease, growing geriatric population, and rising adoption of unhealthy lifestyles are among the primary growth drivers for the coronary stent market. Furthermore, advancements in stent technologies, such as drug-eluting stents and bioresorbable stents, have also contributed to market expansion.

Growth Drivers & Opportunity:

One of the major growth drivers for the coronary stent market is the increasing prevalence of coronary artery disease (CAD) worldwide. According to the World Health Organization, CAD is the leading cause of death globally, accounting for over 7 million deaths in 2016. As the incidence of CAD continues to rise, the demand for coronary stents for the treatment of blocked arteries is expected to increase as well.

Another key factor driving market growth is the growing geriatric population. The elderly are more susceptible to CAD, leading to a higher demand for coronary stents. Additionally, the rising adoption of unhealthy lifestyles, such as smoking, physical inactivity, and unhealthy diets, has contributed to the increasing prevalence of CAD, further fueling the demand for coronary stents.

Report Scope

Report Coverage	Details
Segments Covered	By Product Type, Design, Material, End-User
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific, C. R. Bard, Microport Scientific, Terumo, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group,., and Stentys SA.

Industry Restraints & Challenges:

Despite the growth drivers, the coronary stent market also faces several restraints and challenges. One of the main challenges is the high cost of coronary stent procedures, which can limit market growth, particularly in emerging economies where healthcare infrastructure and affordability are major concerns.

Furthermore, the market is also hindered by the risk of complications associated with stent implantation, such as restenosis, thrombosis, and stent fracture. These complications can lead to additional healthcare costs and negatively impact patient outcomes, posing a challenge for market growth.

Regional Forecast:

The coronary stent market is segmented into several key regions, each with its own dynamics and opportunities for growth.

North America:

North America is expected to dominate the global coronary stent market, driven by the high prevalence of CAD and the presence of advanced healthcare infrastructure. In addition, the region benefits from a strong focus on research and development, leading to the introduction of innovative stent technologies. However, market growth in North America is also hindered by stringent regulatory requirements and the high cost of stent procedures.

Asia Pacific:

Asia Pacific is anticipated to be the fastest-growing region in the global coronary stent market, attributed to the rapid urbanization, changing lifestyles, and increasing healthcare expenditure. The region also presents lucrative opportunities for market players due to the large patient population and unmet medical needs. However, market growth in Asia Pacific is constrained by the presence of a large number of local manufacturers, leading to price competition and pricing pressures.

Europe:

Europe is projected to hold a significant share of the global coronary stent market, driven by the high adoption of advanced stent technologies and the presence of well-established healthcare infrastructure. However, market growth in Europe is hampered by the increasing regulatory scrutiny on stent safety and efficacy, as well as reimbursement challenges in certain countries.

In conclusion, the global coronary stent market is expected to experience substantial growth in the coming years, driven by the increasing prevalence of CAD and the growing geriatric population. However, the market also faces challenges such as high procedure costs and the risk of complications associated with stent implantation. The regional forecast highlights the differing market dynamics and opportunities across North America, Asia Pacific, and Europe, with each region presenting its own set of growth drivers and challenges for market players to navigate.

Segmentation Analysis:

Drug-Eluting Stents:

Drug-eluting stents are a type of coronary stent that are coated with a drug to help prevent the re-narrowing of the artery. These stents are especially effective in patients who are at high risk for restenosis, or the re-narrowing of the artery, as they help to reduce the risk of this occurring. The drug coating helps to inhibit the growth of scar tissue, which can lead to restenosis. Drug-eluting stents have become increasingly popular in the market due to their ability to improve patient outcomes and reduce the need for repeat procedures.

Bioresorbable Stents:

Bioresorbable stents are a newer type of coronary stent that are designed to be absorbed by the body over time. These stents are made from a material that dissolves and is gradually absorbed into the bloodstream, leaving behind only natural artery tissue. Bioresorbable stents offer several potential benefits over traditional metal stents, including a reduced risk of late stent thrombosis and the ability to restore normal vasomotion. While bioresorbable stents are still relatively new to the market, they have the potential to revolutionize the treatment of coronary artery disease.

Competitive Landscape:

The coronary stent market is highly competitive, with a number of major players vying for market share. Some of the key players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc., and Terumo Corporation. These companies are constantly innovating and developing new stent technologies in order to stay ahead of the competition. In addition to these major players, there are also a number of smaller companies and startups that are working to bring new stent technologies to market. This intense competition has led to a rapid pace of innovation in the coronary stent market, with new and improved stent technologies being introduced on a regular basis. As the market continues to grow, competition is only expected to increase, further driving innovation and pushing the boundaries of what is possible in the treatment of coronary artery disease.